Leadiant Biosciences, S.p.A is a Rome-based global holding company, with subsidiaries in the US (Leadiant Biosciences, Inc.) and Europe (Leadiant Biosciences, Ltd, Leadiant Biosciences SASU and Leadiant GmbH). For region or country-specific product information, use the dropdown below.
| Brand Name (active ingredient) | Disease Area | Region/Country of Approval | Affiliated Company |
| (Chenodeoxycholic acid) | Metabolic | Europe | Leadiant Biosciences Ltd. |
| Natulan (procarbazine) | Oncology | Europe | Leadiant Biosciences Ltd. |
| Abelcet® (amphotericin B lipid complex injection) | Infectious Disease | US, Canada | Leadiant Biosciences, Inc. |
| * Adagen® (pegademase bovine)
Revcovi® (recombinant adenosine deaminase) |
Immunology | US | Leadiant Biosciences, Inc. |
| Carnitor® (levocarnitine) Tablets, Oral Solution, Sugar-Free Oral Solution, and Injection | Metabolic disease/ Nephrology | US | Leadiant Biosciences, Inc. |
| Carnitor® (levocarnitine) Tablets, Oral Solution, and Injection | Metabolic disease/ Nephrology | Canada | Leadiant Biosciences, Inc. |
| Cystaran® (cysteamine ophthalmic solution) 0.44% | Metabolic disease/ Ophthalmology | US | Leadiant Biosciences, Inc. |
| Matulane® (procarbazine hydrochloride) | Oncology | US | Leadiant Biosciences, Inc. |
Marketed products
| Brand name (active ingredient) | Disease Area | Region/Country of approval | Affiliated Company |
| Chenodeoxycholic acid Leadiant (chenodeoxycholic acid) | Metabolic | Europe | Leadiant Biosciences, Ltd. |
| Natulan (procarbazine hydrochoride) | Oncology | Europe | Leadiant Biosciences, Ltd. |
| Abelcet® (amphotericin B lipid complex injection) | Infectious disease | US, Canada | Leadiant Biosciences, Inc. |
| *Adagen® (pegademase bovine)
RevcoviTM (recombinant adenosine deaminase) |
Immunology | US | Leadiant Biosciences, Inc. |
| Carnitor® (levocarnitine) Tablets, Oral Solution, Sugar-Free Oral Solution, and Injection | Metabolic disease/Nephrology | US | Leadiant Biosciences, Inc. |
| Carnitor® (levocarnitine) Tablets, Oral Solution, and Injection | Metabolic disease/Nephrology | Canada | Leadiant Biosciences, Inc. |
| Cystaran® (cysteamine ophthalmic solution) 0.44% | Metabolic disease / ophthalmology | US | Leadiant Biosciences, Inc. |
| Matulane® (procarbazine hydrochloride) | Oncology | US, Canada | Leadiant Biosciences, Inc. |
*Adagen® no longer available from 2019, to be replaced by Revcovi®
Updated June 2019
Important Note
For patients: if you wish to report an adverse event related to one of our products, please contact your healthcare provider. In addition, you can contact us on safety@leadiantbiosciences.com.
For healthcare professionals: if you wish to report an adverse event related to one of our products, please follow the current regulatory procedure in force in your country or contact us at safety@leadiantbiosciences.com.
For patients or healthcare professionals in the United States and Canada: if you wish to report an adverse event related to one of our products, please contact us at leadiant@tmacmail.com.
